Core Insights - The health data trading market in China is beginning to take shape, with notable transactions occurring, such as the sale of MRI data by hospitals, indicating a growing interest in monetizing health data assets [1] - Despite the increasing number of health data suppliers, the market is still facing challenges in matching supply and demand, leading to slow growth in the health data trading market [2][3] Supply Side Analysis - The process of transforming raw data into tradable health data involves several costly and time-consuming steps, including data collection, governance, legal assessment, asset establishment, and platform trading [3][4] - The costs associated with data governance can exceed 100,000 yuan for a single imaging dataset, which may deter participation from secondary hospitals and private medical institutions [5][6] Compliance Issues - The ownership and compliance of health data remain contentious, with suppliers often hesitant to engage in data trading due to unclear rights regarding data ownership [6][7] - A clear legal framework is needed to define the rights of data ownership and usage, which could take an estimated 2-3 years to establish [7] Demand Side Analysis - There is a persistent demand for health data, but the limited availability of tradable data assets and the lack of competitive offerings hinder market growth [8] - The absence of a fair pricing system for health data also contributes to the slow progress of transactions in the market [8] Value of Health Data Trading - The emergence of health data trading could significantly enhance the reuse of high-quality data, benefiting AI development in healthcare by providing access to diverse datasets [9][10] - The potential for health data to improve drug development and hospital operational efficiency presents a substantial opportunity for the industry, with estimates suggesting a potential market worth hundreds of billions [10]
国内的健康数据交易卡在了哪里？
3 6 Ke·2025-09-30 02:18